Genetic and Epigenetic Changes at Secondary Resistance after Continued Treatment in the Randomized Phase II Study of All-Trans Retinoic Acid (ATRA) and/or Valproic Acid (VPA) Added to Decitabine (DAC) in Newly Diagnosed Elderly AML Patients (DECIDER Trial)
| Autor: | Hund, Inga *, Hess, Maria *, Stomper, Julia *, Greve, Gabriele *, Mitschke, Jan *, Niemöller, Christoph *, Ma, Tobias *, Uhl, David *, Thol, Felicitas R., Heuser, Michael, Bug, Gesine *, Crysandt, Martina *, Mueller, Lutz Peter *, Neubauer, Andreas, Duyster, Justus *, Dohner, Hartmut, Boerries, Melanie *, Becker, Heiko *, Luebbert, Michael |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:3383-3384 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|